| 书目名称 | Optimizing Breast Cancer Management | | 编辑 | William J. Gradishar | | 视频video | | | 概述 | Focuses on recent data that influence surgical techniques, radiation therapy techniques, and medical therapeutics.Discusses new insights into genetic and lifestyle risks for breast cancer and risk red | | 丛书名称 | Cancer Treatment and Research | | 图书封面 |  | | 描述 | This book presents expert opinions on a variety of key topics related to the management of breast cancer, with a focus on the implications of recent advances and research findings for clinical practice. It also explores the controversy regarding mammography screening and reviews the contribution of new imaging modalities. Considerable attention is paid to developments in surgical procedures, including the potential for the safe and effective use of sentinel lymph node dissection alone—even in patients with positive nodes—and to the advantages and contraindications of new radiotherapy techniques. Genetic aspects are discussed in detail, including an assessment of the role of genetic testing and the potential impact of genetic signatures on breast cancer management. New systemic strategies, such as anti-HER2 therapy, endocrine agents, and agents to reverse endocrine resistance, are considered, and the optimal use of chemotherapy for early-stage and advanced-stage disease is addressed. Inclosing, the book shares important new insights into lifestyle risk factors, risk reduction strategies, and survivor issues, including sexual dysfunction and fertility maintenance. | | 出版日期 | Book 2018 | | 关键词 | Anti - HER2 Therapy; Bisphosphonates; Endocrine Resistance; Non-invasive Breast Cancer; Sentinel Lymph N | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-319-70197-4 | | isbn_softcover | 978-3-319-88901-6 | | isbn_ebook | 978-3-319-70197-4Series ISSN 0927-3042 Series E-ISSN 2509-8497 | | issn_series | 0927-3042 | | copyright | Springer International Publishing AG 2018 |
The information of publication is updating
|
|
发表于 2025-3-21 17:26:16
